(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number for this requirement is NIH-OLAO-OD3-RFP5304230 and this is a Request for Proposal for RNA Extraction from PAXGene RNA tubes.  This solicitiation is in response to sources sought notice NIH-OLAO-OD3-SS-19-5304230
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-02.
(iv) This acquisition is a small business set-aside. The North American Industry Classification System (NAICS) Code for this acquisition is 541714, and the small-business size standards is 1,000 employees.
(v) All descriptions and items needed are included in the Statement of Work (SOW) attached.
(vi) This is a fixed-price requirement. Offeror should be aware that the Government will determine award based on best value - using trade-offs. Please see Evaluation Criteria attached to this solicitation.
(vii) The period of performance will be 12 months.

The following clauses apply to this acquisition:

(viii) The provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition and a statement regarding any addenda to the provision.
(ix) The provision at 52.212-2, Evaluation-Commercial Items, is applicable. The specific evaluation criteria in paragraph (vi) is included within the attachment entitled Evaluation Criteria - RFP5304230.
(x) Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer, or submit a printout to their Online Reps and Certs.
(xi) The clause at 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. The clause, as well as any addenda to the clause, are included in the attachment entitled "Additional Provisions - RFP534230".
(xii) The clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. Applicable clauses can be found in the attachment entitled "Additional Provisions - RFP5304230".
(xiii) Any additional contract requirement(s) or terms and conditions (such as contract financing arrangements or warranty requirements) determined by the contracting officer to be necessary for this acquisition and consistent with customary commercial practices can be found in the attachment entitled "Provisions for Commercial Items". There is no Defense Priorities and Allocations System (DPAS) rating assigned to this acquisition.
(xiv) In order to be considered for an award, an offeror must have completed the online electronic Representations and Certifications located at https://www.sam.gov in accordance with FAR 4.1201(a). By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in SAM at https://www.sam.gov/ prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation [Note: Lack of registration in the System for Award Management will make an offeror ineligible for award.] All responsible sources may submit an offer that will be considered by the Agency.
(xv) Place of Delivery

Address: National Institutes of Health, NIH Animal Center, Elmer School Road, Poolesville, MD
Postal Code: 20837

(xvi) Offers must be submitted via e-mail no later than 5:00 P.M. Eastern Daylight Time on Monday, May 20, 2019. E-mail submissions to [email protected] and [email protected]  by required response time. Fax submissions are not authorized. Requests for further information or questions concerning this requirement must be submitted in writing to [email protected].
(xvii) Point of Contact
Anne Mineweaser, Contracting Officer, Phone 301-827-7683. Email [email protected] .